— Know what they know.
Not Investment Advice

RASP OTC

Actavia Life Sciences, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -87.5% 3Y: -95.0% 5Y: -99.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $385906 mcap · 114M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$96K +12.2% ▲
5Y CAGR: -55.1%
Total Liabilities
$2M +15.7% ▲
5Y CAGR: -0.7%
Shareholders Equity
-$2M -15.8% ▼
Cash & Investments
$75K +90.5% ▲
5Y CAGR: +11.9%
Total Debt
$211K -4.0% ▼
5Y CAGR: +9.0%
Net Debt
$136K -24.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$50K$14K$11K$39K$75K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$50K$14K$11K$39K$75K
Net Receivables$14K$748$34K$46K$21K
Inventory-$14K-$748-$34K-$46K-$21K
Other Current Assets$22K$748$0$0$0
Total Current Assets$72K$33K$45K$85K$96K
Property, Plant & Equip.$2K$314$0$0$0
Goodwill & Intangibles$5M$0$0$0$0
Long-Term Investments-$849K$0$0$0$0
Other Non-Current Assets$846K$0$0$0$0
Total Non-Current Assets$5M$314$0$0$0
Total Assets$5M$33K$45K$85K$96K
— Liabilities —
Accounts Payable$864K$952K$900K$822K$960K
Short-Term Debt$265K$522K$683K$128K$211K
Deferred Revenue$0$0$1M$0$0
Other Current Liabilities$0$0-$1M$8K$2K
Total Current Liabilities$2M$3M$3M$2M$2M
Long-Term Debt$0$0$0$92K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$3K$1M$0$92K$0
Total Liabilities$2M$3M$3M$2M$2M
— Equity —
Common Stock$69K$69K$69K$180K$772K
Retained Earnings-$17M-$23M-$23M-$24M-$29M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$3M-$3M-$3M-$2M-$2M
Total Liabilities & Equity$5M$33K$45K$85K$96K
— Key Metrics —
Total Debt$265K$522K$592K$220K$211K
Net Debt$215K$508K$581K$180K$136K
Total Investments-$849K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms